On October 19, Andy Doraiswamy will take the stage at the Goldman Sachs Healthcare Private Company Conference in New York City. The following day, CFO Damian Rippole will present at The MedTech Conference, hosted by AdvaMed in Boston. Both executives aim to demonstrate the company’s recent progress in treating chronic edema through its flagship Dayspring compression treatment. Beyond current commercial performance, the leadership team plans to provide updates on ongoing clinical research and the broader development of the firm’s vascular product pipeline.
In section Releases
Koya Medical Executives to Outline Vascular Growth Strategy
Dallas-based Koya Medical is heading to the East Coast this October to showcase its vascular technology portfolio at two major investor forums. CEO Andy Doraiswamy and CFO Damian Rippole will lead the company’s presentations, focusing on commercial traction and the clinical research pipeline behind their non-pneumatic compression therapies.
Comments (0)
No comments yet. Be the first!